CAS: 219649-07-7 - Labetuzumab
Formula:Unspecified
- Synonyms:
- Antibody hMN 14
- Immunoglobulin G, anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 γ-chain), disulfide with human-mouse monoclonal hMN-14 κ-chain, dimer
- Labetuzumab
- hMN-14
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Labetuzumab REF: TM-T9901A-004CAS: 219649-07-7 | SDS-PAGE: 95.2%；SEC-HPLC: 95.6% | 327.00 €~2,778.00 € | Thu 24 Oct 24 |
 | Labetuzumab REF: 3D-CLA1068CAS: 219649-07-7 | - - - | To inquire | Tue 05 Nov 24 |
Labetuzumab
CAS:219649-07-7
Labetuzumab (hMN-14) is an anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity for the study …
Purity:
SDS-PAGE: 95.2%；SEC-HPLC: 95.6%
Color and Shape:
Soild
Molecular weight:
145.1 kDa
Ref: TM-T9901A-004
| 1mg | 327.00 € | ||
| 2mg | 449.00 € | ||
| 5mg | 655.00 € | ||
| 10mg | 1,027.00 € | ||
| 25mg | 1,563.00 € | ||
| 50mg | 2,100.00 € | ||
| 100mg | 2,778.00 € |
Estimated delivery in United States, on Thursday 24 Oct 2024
Ref: 3D-CLA1068
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 5 Nov 2024
